Tower Research Capital (TRC)’s OSR Health OSRH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.08K Buy
6,587
+2,446
+59% +$1.23K ﹤0.01% 4722
2026
Q1
$2.5K Sell
4,141
-9
-0.2% -$5 ﹤0.01% 4468
2025
Q4
$2.34K Sell
4,150
-9
-0.2% -$6 ﹤0.01% 4550
2025
Q3
$2.23K Buy
4,159
+3,259
+362% +$2.61K ﹤0.01% 4667
2025
Q2
$1.24K Sell
900
-1,640
-65% -$2.28K ﹤0.01% 4845
2025
Q1
$4.78K Buy
2,540
+2,435
+2,319% +$13.4K ﹤0.01% 4200
2024
Q4
$1.2K Hold
105
﹤0.01% 5065
2024
Q3
$1.14K Hold
105
﹤0.01% 5200
2024
Q2
$1.13K Buy
105
+6
+6% +$64 ﹤0.01% 5200
2024
Q1
$1.06K Hold
99
﹤0.01% 5335
2023
Q4
$1.04K Buy
99
+3
+3% +$31 ﹤0.01% 5454
2023
Q3
$998 Hold
96
﹤0.01% 5434
2023
Q2
$985 Buy
+96
New +$977 ﹤0.01% 5502

Other funds holding OSRH

Tower Research Capital (TRC)'s OSRH Position: Q2 2026 in Review

Tower Research Capital (TRC) increased its OSR Health (OSRH) stake by 59% in Q2 2026, buying an estimated $1.23K and bringing the position to 6,587 shares worth $2.08K. The position accounts for ﹤0.01% of the portfolio, ranked #4722.

Tower Research Capital (TRC) first reported a position in OSRH in Q2 2023 and has held it in 13 quarters since. The position peaked at $4.78K in Q1 2025. 13 funds tracked by Wall St. Rank hold OSRH as of Q2 2026.

  • Tower Research Capital (TRC) held 6,587 shares of OSR Health worth $2.08K as of Q2 2026.
  • Tower Research Capital (TRC) bought 2,446 OSR Health shares in Q2 2026, an estimated $1.23K.
  • OSR Health made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #4722 holding.
  • Tower Research Capital (TRC) first reported a position in OSR Health in Q2 2023 and has held it in 13 quarters since.
  • Tower Research Capital (TRC)'s OSR Health position peaked at $4.78K in Q1 2025.
  • 13 funds tracked by Wall St. Rank held OSR Health as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.